These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 16239721)

  • 1. Novel multisubstrate inhibitors of mammalian purine nucleoside phosphorylase.
    Toms AV; Wang W; Li Y; Ganem B; Ealick SE
    Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1449-58. PubMed ID: 16239721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
    Luić M; Koellner G; Yokomatsu T; Shibuya S; Bzowska A
    Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1417-24. PubMed ID: 15272165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1.45 A resolution crystal structure of recombinant PNP in complex with a pM multisubstrate analogue inhibitor bearing one feature of the postulated transition state.
    Chojnowski G; Breer K; Narczyk M; Wielgus-Kutrowska B; Czapinska H; Hashimoto M; Hikishima S; Yokomatsu T; Bochtler M; Girstun A; Staroń K; Bzowska A
    Biochem Biophys Res Commun; 2010 Jan; 391(1):703-8. PubMed ID: 19944078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New catalytic mechanism for human purine nucleoside phosphorylase.
    Canduri F; Fadel V; Basso LA; Palma MS; Santos DS; de Azevedo WF
    Biochem Biophys Res Commun; 2005 Feb; 327(3):646-9. PubMed ID: 15649395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of 9-deazaguanine derivatives as multi-substrate analogue inhibitors of PNP.
    Hashimoto M; Hikishima S; Magnowska L; Bzowska A; Yokomatsu T
    Nucleic Acids Symp Ser (Oxf); 2007; (51):431-2. PubMed ID: 18029771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-Deazaguanine derivatives: synthesis and inhibitory properties as multi-substrate analogue inhibitors of mammalian PNPs.
    Yatsu T; Hashimoto M; Hikishima S; Magnowska L; Bzowska A; Yokomatsu T
    Nucleic Acids Symp Ser (Oxf); 2008; (52):661-2. PubMed ID: 18776553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Aza-immucillins as transition-state analogue inhibitors of purine nucleoside phosphorylase and nucleoside hydrolases.
    Evans GB; Furneaux RH; Gainsford GJ; Hanson JC; Kicska GA; Sauve AA; Schramm VL; Tyler PC
    J Med Chem; 2003 Jan; 46(1):155-60. PubMed ID: 12502369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of calf spleen purine nucleoside phosphorylase with two full trimers in the asymmetric unit: important implications for the mechanism of catalysis.
    Bzowska A; Koellner G; Wielgus-Kutrowska B; Stroh A; Raszewski G; Holý A; Steiner T; Frank J
    J Mol Biol; 2004 Sep; 342(3):1015-32. PubMed ID: 15342253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the purine nucleoside phosphorylase (PNP) from Cellulomonas sp. and its implication for the mechanism of trimeric PNPs.
    Tebbe J; Bzowska A; Wielgus-Kutrowska B; Schröder W; Kazimierczuk Z; Shugar D; Saenger W; Koellner G
    J Mol Biol; 1999 Dec; 294(5):1239-55. PubMed ID: 10600382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the structural basis for specificity of ligands using crystallographic screening.
    de Azevedo WF; Canduri F; Basso LA; Palma MS; Santos DS
    Cell Biochem Biophys; 2006; 44(3):405-11. PubMed ID: 16679527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures for the potential drug target purine nucleoside phosphorylase from Schistosoma mansoni causal agent of schistosomiasis.
    Pereira HD; Franco GR; Cleasby A; Garratt RC
    J Mol Biol; 2005 Oct; 353(3):584-99. PubMed ID: 16182308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanine, pyrazolo[3,4-d]pyrimidine, and triazolo[4,5-d]pyrimidine (8-azaguanine) phosphonate acyclic derivatives as inhibitors of purine nucleoside phosphorylase.
    Beauchamp LM; Tuttle JV; Rodriguez ME; Sznaidman ML
    J Med Chem; 1996 Feb; 39(4):949-56. PubMed ID: 8632418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of calf spleen purine nucleoside phosphorylase complexed to a novel purine analogue.
    Pereira HM; Berdini V; Cleasby A; Garratt RC
    FEBS Lett; 2007 Oct; 581(26):5082-6. PubMed ID: 17927987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of calf spleen purine nucleoside phosphorylase in a complex with multisubstrate analogue inhibitor with 2,6-diaminopurine aglycone.
    Koellner G; Stroh A; Raszewski G; Holý A; Bzowska A
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1699-702. PubMed ID: 14565499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
    Miles RW; Tyler PC; Furneaux RH; Bagdassarian CK; Schramm VL
    Biochemistry; 1998 Jun; 37(24):8615-21. PubMed ID: 9628722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open and closed conformation of the E. coli purine nucleoside phosphorylase active center and implications for the catalytic mechanism.
    Koellner G; Bzowska A; Wielgus-Kutrowska B; Luić M; Steiner T; Saenger W; Stepiński J
    J Mol Biol; 2002 Jan; 315(3):351-71. PubMed ID: 11786017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative activity of purine nucleoside phosphorylase multisubstrate analogue inhibitors containing difluoromethylene phosphonic acid against leukaemia and lymphoma cells.
    Glavas-Obrovac L; Suver M; Hikishima S; Hashimoto M; Yokomatsu T; Magnowska L; Bzowska A
    Chem Biol Drug Des; 2010 Apr; 75(4):392-9. PubMed ID: 20102369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics.
    Keough DT; Hocková D; Holý A; Naesens LM; Skinner-Adams TS; Jersey Jd; Guddat LW
    J Med Chem; 2009 Jul; 52(14):4391-9. PubMed ID: 19527031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based drug design: inhibitors of purine nucleoside phosphorylase.
    Montgomery JA
    Farmaco; 1993 Feb; 48(2):297-308. PubMed ID: 8494600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic studies of interactions of calf spleen PNP with acyclic phosphonate inhibitors.
    Breer K; Wielgus-Kutrowska B; Hashimoto M; Hikishima S; Yokomatsu T; Szczepanowski RH; Bochtler M; Girstun A; Starón K; Bzowska A
    Nucleic Acids Symp Ser (Oxf); 2008; (52):663-4. PubMed ID: 18776554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.